The Journal of Bone and Joint Surgery (American). 2007;89:2113-2123.
doi:10.2106/JBJS.F.01530
© 2007 The Journal of Bone and Joint Surgery, Inc.
Reliability of Histopathologic and Radiologic Grading of Cartilaginous Neoplasms in Long Bones
the Skeletal Lesions Interobserver Correlation among Expert
Diagnosticians (SLICED) Study Group
Investigation coordinated from the University of Iowa, Iowa City,
Iowa
Disclosure: The authors did not receive any outside funding or
grants in support of their research for or preparation of this work. Neither
they nor a member of their immediate families received payments or other
benefits or a commitment or agreement to provide such benefits from a
commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, division, center,
clinical practice, or other charitable or nonprofit organization with which
the authors, or a member of their immediate families, are affiliated or
associated.
This manuscript was prepared by the Skeletal Lesions Interobserver
Correlation among Expert Diagnosticians (SLICED) Study Group, c/o Kevin B.
Jones, MD, Department of Orthopaedics and Rehabilitation, University of Iowa
Hospitals and Clinics, 200 Hawkins Drive, 01051 John Pappajohn Pavilion, Iowa
City, IA 52242. E-mail address:
kbjones{at}post.harvard.edu.
Principal Investigators: Kevin B. Jones, MD, and Joseph A. Buckwalter, MD, MS
(University of Iowa Hospitals and Clinics). Pathology Lead Investigators:
Edward F. McCarthy, MD (Johns Hopkins Medical Institutions) and Barry R.
DeYoung, MD (University of Iowa Hospitals and Clinics). Radiology Lead
Investigator: Georges Y. El-Khoury, MD (University of Iowa Hospitals and
Clinics). Statistical Planning and Analysis: Lori Dolan, PhD. Pathologists:
Barry R. DeYoung, MD (University of Iowa Hospitals and Clinics), Francis H.
Gannon, MD (Baylor College of Medicine), Carrie Y. Inwards, MD (Mayo Clinic
Rochester), Michael J. Klein, MD (University of Alabama at Birmingham),
Michael Kyriakos, MD (Washington University, St. Louis), Edward F. McCarthy,
MD (Johns Hopkins Medical Institutions), Andrew E. Rosenberg, MD
(Massachusetts General Hospital), Gene P. Siegal, MD, PhD (University of
Alabama at Birmingham), K. Krishnan Unni, MD (Mayo Clinic Rochester).
Radiologists: Georges Y. El-Khoury, MD (University of Iowa Hospitals and
Clinics), Laura Fayad, MD (Johns Hopkins Medical Institutions), Mark J.
Kransdorf, MD (Mayo Clinic Jacksonville), Mark D. Murphey, MD (Armed Forces
Institute of Pathology), David M. Panicek, MD (Memorial Sloan-Kettering Cancer
Center), David A. Rubin, MD (Washington University, St. Louis), Murali
Sundaram, MD (Cleveland Clinic), and Daniel Vanel, MD (Institut Gustave
Roussy, Villejuif CEDEX, France).
Background: Providing the best treatment options and appropriate
prognostic information to patients with cartilaginous neoplasms of long bones
depends on distinguishing benign from malignant lesions. Correlative
interpretation of imaging, histopathology, and clinical information is the
current method for making this distinction, yet the reliability of this
approach has not been critically evaluated. This study quantifies the
interobserver reliability of the determination of grade for cartilaginous
neoplasms among a group of experienced musculoskeletal pathologists and
radiologists.
Methods: Nine recognized musculoskeletal pathologists and eight
recognized musculoskeletal radiologists reviewed forty-six consecutive cases
of cartilaginous lesions in long bones that underwent open biopsy or
intralesional curettage. All diagnosticians had a bulleted history and
preoperative conventional radiographs for review. Pathologists reviewed the
original hematoxylin and eosin-stained glass slides from each case.
Radiologists reviewed any additional imaging that was available, variably
including serial radiographs, magnetic resonance imaging, and computed
tomography scans. Each diagnostician classified a lesion as benign, low-grade
malignant, or high-grade malignant. Kappa coefficients were calculated as a
measure of reliability.
Results: Kappa coefficients for interrater reliability were 0.443
for the pathologists and 0.345 for the radiologists (p < 0.0001 for both).
Kappa coefficients for a subgroup of cases determined to be high risk by
subsequent clinical course were poorer at 0.236 and 0.206, respectively (p
< 0.0001 for both). Slightly improved agreement among radiologists was
noted for the twenty lesions that had magnetic resonance imaging available
(Kappa = 0.437, p < 0.0001), but not for the lesions analyzed with serial
plain radiographs or computed tomography scans.
Conclusions: This study demonstrates low reliability for the grading
of cartilaginous lesions in long bones, even among specialized and experienced
pathologists and radiologists. This included low reliability both in
differentiating benign from malignant lesions and in differentiating
high-grade from low-grade malignant lesions, both of which are critical to the
safe treatment of these neoplasms. This may explain in part the wide variation
in outcomes reported for chondrosarcomas treated in different medical centers.
New diagnostic and grading strategies linked to protocol-driven treatments are
needed, but they must be measured against the long-term gold standard of
patient outcomes.

CiteULike Connotea Del.icio.us Facebook Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. M. Schrage, I. H. Briaire-de Bruijn, N. F.C.C. de Miranda, J. van Oosterwijk, A. H.M. Taminiau, T. van Wezel, P. C.W. Hogendoorn, and J. V.M.G. Bovee
Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment
Cancer Res.,
August 1, 2009;
69(15):
6216 - 6222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. O. Lewis
What's New in Musculoskeletal Oncology
J. Bone Joint Surg. Am.,
June 1, 2009;
91(6):
1546 - 1556.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Y. Giuffrida, J. E. Burgueno, L. G. Koniaris, J. C. Gutierrez, R. Duncan, and S. P. Scully
Chondrosarcoma in the United States (1973 to 2003): An Analysis of 2890 Cases from the SEER Database
J. Bone Joint Surg. Am.,
May 1, 2009;
91(5):
1063 - 1072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Gelderblom, P. C.W. Hogendoorn, S. D. Dijkstra, C. S. van Rijswijk, A. D. Krol, A. H.M. Taminiau, and J. V.M.G. Bovee
The Clinical Approach Towards Chondrosarcoma
Oncologist,
March 1, 2008;
13(3):
320 - 329.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|